Skip to content
★ Sign in to follow
Eve Health Group Limited. logo

Eve Health Group Limited. Stock: price and insider trades · Australia

ISIN AU000000EVE3AU·Mcap A$5.3MFood & Beverage

1 insider bought €2,507 of shares over the last 90 days, the latest by Stuart Gunzburg, filed 27 Oct 2026.

Eve Health Group Limited.: what insiders have been doing

This page follows insider dealings at Eve Health Group Limited. as filed with ASX, a company from the Food & Beverage sector. In the past year (28 October 2025 to 28 October 2026), 7 filings came from 4 insiders.

Both sides are active: 3 purchases worth €20k and 2 sales, from 2 insiders and 1 insider respectively. No amount is published for 2 filings, which the totals therefore leave out. Unlike grants, an open-market purchase is paid for by the insider, at the market price. One trade stands out by size: a purchase of €11k from Gregory William Fry, disclosed on 22 May 2026. The buyers include 2 senior executives.

The last insider purchase was made public on 27 October 2026, 12 days ago. The median gap between a trade and its publication by ASX is 1 day. Until a filing is published, the market cannot know about the trade.

With 7 filings in twelve months, the company is more active than the median of 5 filings across the 1,602 companies we follow on the same exchange. The full history, which starts in 2026, counts 3 purchases against 2 sales.

These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.

Insider Decl.
7
Thresholds
n/a
Buy Volume
€19,620
3 ops. · all time
Sell Volume
n/a
2 ops. · all time

Who traded when

BuySale
Stuart Gunzburg2 buys2 sales
Gregory William Fry1 buy

Since the insiders bought

  • Filed 22 May 2026 · 170 days ago · €11k
    -45.8%
    Entry A$0.02 · Close 26 Oct 2026 A$0.01

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.

Fundamental score
Ranked 24,338 of 26,911 companies
21.3
score / 100
Value
6
Quality
37
FCF yld-41%
Earn yld-45%
EV/EBITDA·
ROE-50%
Gross mgn46%
Net mgn·
Debt/EBITDA·
Pillars2/3

Transparent value + quality ranking, distinct from the insider signal.

Financial data

as of FY 2026

FY ended June 2026 · cache

A$0.02
Analyst consensus
·
Income statement
RevenueA$1.2M
Gross profitA$527.5k46% margin
EBITDA-A$1.8M-152% margin
Net income-A$1.9M-164.0% margin
Valuation
P/Book1.4x
Beta0.40
Balance sheet & cash
Market capA$5.3M
Total debtA$91.3k
Free Cash Flow-A$1.7M
Debt / Equity1%
Profitability & ownership
ROE-50.4%
ROA-28.3%
% insiders57.3%
% institutions0.0%
Last declaration on 27 October 2026
Declarations7 total
  • ●
    Executives
    Executives(filed)
    0ASX
  • ▲
    DirectorExecutives
    4,000 AUD26ASX
    400,000 shares@ A$0.010.076% mcap100.0% of flowShareASXASX:2924-03153754-6A1351672
    Canonical exit: 24 Jan 2027 (T+90)
  • ▼
    Executives
    Executives
    0ASX
  • ▼
    Executives
    Executives
    0ASX
  • ▲
    Executives
    Executives
    17,850 AUD0ASX
  • ▲
    Executives
    Executives
    10,000 AUD0ASX
  • ●
    Substantial HolderExecutives(filed)
    0ASX
    ShareASXASX:2924-03083180-6A1322384

7 of 7 declarations

About Eve Health Group Limited.

EVE HEALTH GROUP LIMITED is a company listed on the XASX, specializing in the healthcare sector. It focuses on developing innovative solutions to enhance patient well-being.